IL-17 upregulated VEGF-C levels in NSCLC cells through the p-ERK1/2 kinase pathway, which enhanced LECs chemotaxis and endothelial cord formation [93, 94]. This evidence concerns the gene VEGFC and non-small cell lung carcinoma.